Use of vitamin D analogs in renal osteodystrophy.
D015652:25-Hydroxyvitamin D 2; D002117:Calcitriol / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D002762:Cholecalciferol / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000209:etiology; D004097:Dihydrotachysterol / Q000627:therapeutic use; D004872:Ergocalciferols / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D010018:Osteomalacia / Q000517:prevention & control; D010281:Parathyroid Hormone / Q000378:metabolism; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004872:Ergocalciferols; D010281:Parathyroid Hormone; D014807:Vitamin D; D002762:Cholecalciferol; D015652:25-Hydroxyvitamin D 2; D002117:Calcitriol; D004097:Dihydrotachysterol; D002118:Calcium